Best General Drug Manufacturer Stocks to Buy Now (2025)Top general drug manufacturer stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best general drug manufacturer stocks to buy now. Learn More.
Industry: Drug Manufacturers - Gene...
A
General Drug Manufacturers is Zen Rated A and is the 5th ranked industry out of 145 stock market industries
Learn how the Zen Ratings work| Ticker | Company | Price | 1d % | 1w % | 1m % | 3m % | 6m % | 1y % | 3y % | 5y % | 10y % | 52-week High | 52-week Low | % off 52-week High | % off 52-week Low | Beta | Volume | Vol 1d % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NVS | NOVARTIS AG | $121.02 | -2.19% | -0.90% | 2.50% | 12.56% | 21.91% | 9.52% | 43.24% | 40.59% | 16.24% | $124.83 | $96.06 | 3.05% | 25.98% | 0.35 | 2,754,000 | 65.21% |
| JNJ | JOHNSON & JOHNSON | $156.90 | -0.50% | 1.05% | 1.06% | 3.41% | 8.60% | 4.81% | -12.03% | 8.05% | 56.48% | $169.99 | $140.68 | 7.70% | 11.53% | 0.26 | 7,872,000 | 16.92% |
| GRFS | GRIFOLS SA | $9.74 | -0.10% | 9.81% | 8.83% | 44.08% | 34.72% | 10.06% | -11.78% | -47.80% | -38.12% | $9.96 | $6.19 | 2.21% | 57.35% | 0.75 | 904,000 | -40.05% |
| GILD | GILEAD SCIENCES INC | $109.64 | -4.28% | -1.91% | 0.31% | 5.80% | 21.90% | 56.70% | 74.98% | 42.98% | -4.29% | $119.96 | $70.21 | 8.60% | 56.16% | 0.43 | 6,115,000 | 0.30% |
| GSK | GSK PLC | $38.28 | -3.28% | 0.24% | -8.02% | 10.51% | 17.06% | -1.59% | -27.55% | -23.57% | -28.60% | $44.67 | $31.72 | 14.30% | 20.70% | 0.38 | 6,300,000 | 3.50% |
| AMGN | AMGEN INC | $295.27 | -1.70% | 0.79% | 1.19% | 3.25% | 9.28% | -9.17% | 19.17% | 18.09% | 89.57% | $346.85 | $253.30 | 14.87% | 16.57% | 0.48 | 1,620,000 | -15.89% |
| BMY | BRISTOL MYERS SQUIBB CO | $46.86 | -3.42% | 0.80% | -6.58% | -7.59% | -15.35% | 14.99% | -37.98% | -18.86% | -32.73% | $63.33 | $39.93 | 26.01% | 17.37% | 0.34 | 13,716,000 | -6.90% |
| AZN | ASTRAZENECA PLC | $71.13 | -0.95% | 2.15% | -3.54% | 7.30% | 8.22% | -8.74% | 6.58% | 33.60% | 111.76% | $87.68 | $61.24 | 18.87% | 16.15% | 0.44 | 2,730,000 | -32.54% |
| ABBV | ABBVIE INC | $192.45 | -1.31% | 2.57% | 0.50% | 9.94% | 8.89% | 13.27% | 25.60% | 96.66% | 176.63% | $218.66 | $163.81 | 11.99% | 17.48% | 0.40 | 4,990,000 | -17.51% |
| PFE | PFIZER INC | $25.65 | -0.50% | 1.62% | 4.78% | 17.07% | -4.29% | -10.50% | -51.50% | -27.15% | -26.34% | $31.54 | $20.92 | 18.67% | 22.64% | 0.42 | 34,841,000 | -11.75% |
| SNY | SANOFI | $48.61 | -1.48% | 0.60% | -2.19% | -5.61% | 0.00% | -5.08% | -3.34% | -4.57% | -6.70% | $60.12 | $45.80 | 19.14% | 6.14% | 0.35 | 1,207,000 | -45.61% |
| LLY | ELI LILLY & CO | $793.01 | 0.30% | 2.61% | -1.93% | 8.27% | -0.56% | -15.11% | 139.53% | 389.27% | 792.83% | $972.53 | $677.09 | 18.46% | 17.12% | 0.60 | 2,853,000 | -8.88% |
| SCLX | SCILEX HOLDING CO | $6.46 | -0.46% | 3.36% | 15.56% | -5.89% | -58.35% | -90.63% | -98.20% | N/A | N/A | $73.50 | $3.60 | 91.21% | 79.44% | 0.33 | 84,000 | 26.51% |
| BIIB | BIOGEN INC | $134.21 | -0.83% | 3.14% | 0.86% | 16.53% | -10.63% | -43.32% | -37.65% | -51.46% | -65.70% | $236.48 | $110.04 | 43.25% | 21.97% | 0.77 | 1,045,000 | 5.34% |
| MRK | MERCK & CO INC | $83.36 | -0.79% | 3.04% | 3.78% | 5.28% | -17.45% | -35.36% | -11.60% | 7.77% | 44.05% | $129.03 | $73.31 | 35.39% | 13.71% | 0.31 | 9,717,000 | -34.03% |
| OGN | ORGANON & CO | $9.94 | -0.80% | 2.26% | -1.39% | -11.09% | -36.53% | -52.39% | -69.60% | N/A | N/A | $23.10 | $8.01 | 56.97% | 24.09% | 0.80 | 3,563,000 | -6.48% |
| AMRN | AMARIN CORP PLC | $16.93 | -2.25% | 1.68% | 27.77% | 82.04% | 64.46% | 13.50% | -40.80% | -87.21% | -64.88% | $17.49 | $7.08 | 3.20% | 139.12% | 1.12 | 103,000 | 7.29% |
| MIRA | MIRA PHARMACEUTICALS INC | $1.28 | 6.67% | 11.30% | 5.79% | 47.98% | 7.56% | 113.33% | N/A | N/A | N/A | $5.01 | $0.62 | 74.45% | 107.79% | 1.71 | 2,255,000 | 14.12% |
General Drug Manufacturer Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.